Literature DB >> 16305288

Clinical practice guidelines for bone metabolism and disease in chronic kidney disease: an overview.

George R Bailie1, Shaul G Massry.   

Abstract

The National Kidney Foundation developed and oversees the Kidney Disease Outcomes Quality Initiative, a process that develops clinical practice guidelines in nephrology. Recent guidelines address the aberrations in bone metabolism and disease that occur as a complication of chronic kidney disease. These guidelines provide, for the first time, a standard approach to the detection and management of alterations in calcium, phosphorus, and parathyroid hormone metabolism. The problems and sequelae of soft-tissue calcification are discussed, and recommendations are provided for reducing the associated morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16305288     DOI: 10.1592/phco.2005.25.12.1687

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  9 in total

1.  Impact of Admission Calcium-phosphate Product on 1-year Mortality among Hospitalized Patients.

Authors:  Wisit Cheungpasitporn; Charat Thongprayoon; Panupong Hansrivijit; Juan Medaura; Api Chewcharat; Tarun Bathini; Michael A Mao; Stephen B Erickson
Journal:  Adv Biomed Res       Date:  2020-04-22

Review 2.  Sevelamer hydrochloride: a review of its use for hyperphosphataemia in patients with end-stage renal disease on haemodialysis.

Authors:  David R Goldsmith; Lesley J Scott; Risto S Cvetković; Greg L Plosker
Journal:  Drugs       Date:  2008       Impact factor: 9.546

3.  Low Magnesium Exacerbates Osteoporosis in Chronic Kidney Disease Patients with Diabetes.

Authors:  Jui-Hua Huang; Fu-Chou Cheng; Hsu-Chen Wu
Journal:  Int J Endocrinol       Date:  2015-07-27       Impact factor: 3.257

4.  "Vitamin D supplementation and bone health in adults with diabetic nephropathy: the protocol for a randomized controlled trial".

Authors:  Diana R Mager; Stephanie T Jackson; Michelle R Hoffmann; Kailash Jindal; Peter A Senior
Journal:  BMC Endocr Disord       Date:  2014-08-12       Impact factor: 2.763

5.  Association of kidney function-related dietary pattern, weight status, and cardiovascular risk factors with severity of impaired kidney function in middle-aged and older adults with chronic kidney disease: a cross-sectional population study.

Authors:  Adi Lukas Kurniawan; Chien-Yeh Hsu; Hsiao-Hsien Rau; Li-Yin Lin; Jane C-J Chao
Journal:  Nutr J       Date:  2019-04-22       Impact factor: 3.271

6.  Association of Nutrition Education and Its Interaction with Lifestyle Factors on Kidney Function Parameters and Cardiovascular Risk Factors among Chronic Kidney Disease Patients in Taiwan.

Authors:  Adi-Lukas Kurniawan; Ya-Lan Yang; Mei-Yun Chin; Chien-Yeh Hsu; Rathi Paramastri; Hsiu-An Lee; Po-Yuan Ni; Jane Chao
Journal:  Nutrients       Date:  2021-01-21       Impact factor: 5.717

7.  Relationship between vitamin D deficiency and psychophysiological variables: a systematic review of the literature.

Authors:  Mariluce Rodrigues Marques Silva; Waleska Maria Almeida Barros; Mayara Luclécia da Silva; José Maurício Lucas da Silva; Ana Patrícia da Silva Souza; Ana Beatriz Januário da Silva; Matheus Santos de Sousa Fernandes; Sandra Lopes de Souza; Viviane de Oliveira Nogueira Souza
Journal:  Clinics (Sao Paulo)       Date:  2021-11-08       Impact factor: 2.365

8.  Association between metabolic parameters and risks of anemia and electrolyte disturbances among stages 3-5 chronic kidney disease patients in Taiwan.

Authors:  Adi Lukas Kurniawan; Mei-Yun Chin; Ya-Lan Yang; Chien-Yeh Hsu; Rathi Paramastri; Hsiu-An Lee; Po-Yuan Ni; Jane C-J Chao
Journal:  BMC Nephrol       Date:  2021-11-17       Impact factor: 2.388

9.  Evaluation of patients with a recent clinical fracture and osteoporosis, a multidisciplinary approach.

Authors:  Bianca Dumitrescu; Svenjhalmar van Helden; Rene ten Broeke; Arie Nieuwenhuijzen-Kruseman; Caroline Wyers; Gabriela Udrea; Sjef van der Linden; Piet Geusens
Journal:  BMC Musculoskelet Disord       Date:  2008-08-05       Impact factor: 2.362

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.